BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23503605)

  • 1. Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: a retrospective cohort analysis of recurrent glioblastoma multiforme.
    Archavlis E; Tselis N; Birn G; Ulrich P; Baltas D; Zamboglou N
    BMJ Open; 2013 Mar; 3(3):. PubMed ID: 23503605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.
    Chatzikonstantinou G; Zamboglou N; Archavlis E; Strouthos I; Zoga E; Milickovic N; Hilaris B; Baltas D; Rödel C; Tselis N
    Strahlenther Onkol; 2018 Dec; 194(12):1171-1179. PubMed ID: 30203110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage therapy for recurrent glioblastoma multiforme: a multimodal approach combining fluorescence-guided resurgery, interstitial irradiation, and chemotherapy.
    Archavlis E; Tselis N; Birn G; Ulrich P; Zamboglou N
    Neurol Res; 2014 Dec; 36(12):1047-55. PubMed ID: 24852696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
    Tselis N; Kolotas C; Birn G; Röddiger S; Filipowicz I; Kontova M; Fountzilas G; Selviaridis P; Baltas D; Heyd R; Anagnostopoulos G; Zamboglou N
    Strahlenther Onkol; 2007 Oct; 183(10):563-70. PubMed ID: 17896088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial high-dose-rate brachytherapy in the primary treatment of inoperable glioblastoma multiforme.
    Chatzikonstantinou G; Ulrich P; Archavlis E; Zamboglou N; Strouthos I; Zoga E; Baltas D; Tselis N
    J Contemp Brachytherapy; 2019 Jun; 11(3):215-220. PubMed ID: 31435428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison and effect-to-treatment analysis.
    Roussakow SV
    BMJ Open; 2017 Nov; 7(11):e017387. PubMed ID: 29102988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma.
    Ozyar E; Yildz F; Akyol FH; Atahan IL
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):101-8. PubMed ID: 11777627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy.
    Rudzianskas V; Inciura A; Juozaityte E; Rudzianskiene M; Kubilius R; Vaitkus S; Kaseta M; Adliene D
    Acta Otorhinolaryngol Ital; 2012 Oct; 32(5):297-303. PubMed ID: 23326008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computed tomography-guided interstitial high dose rate brachytherapy for centrally located liver tumours: a single institution study.
    Tselis N; Chatzikonstantinou G; Kolotas C; Milickovic N; Baltas D; Zamboglou N
    Eur Radiol; 2013 Aug; 23(8):2264-70. PubMed ID: 23515917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
    Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
    J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined salvage therapies for recurrent glioblastoma multiforme: evaluation of an interdisciplinary treatment algorithm.
    Archavlis E; Tselis N; Birn G; Ulrich P; Zamboglou N
    J Neurooncol; 2014 Sep; 119(2):387-95. PubMed ID: 24947312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment Option.
    Yaprak G; Isık N; Gemici C; Pekyurek M; Ceylaner Bıcakcı B; Demircioglu F; Tatarlı N
    Stereotact Funct Neurosurg; 2020; 98(3):167-175. PubMed ID: 32248188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
    Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
    Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reirradiation for patients with recurrence head and neck squamous cell carcinoma: a single-institution comparative study.
    Rudžianskas V; Inčiūra A; Vaitkus S; Padervinskis E; Rudžianskienė M; Kupčinskaitė-Noreikienė R; Saltonaitė L; Noreika A; Statnickaitė A; Juozaitytė E
    Medicina (Kaunas); 2014; 50(2):92-9. PubMed ID: 25172603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
    Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S
    Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma.
    Lewitzki V; Klement RJ; Kosmala R; Lisowski D; Flentje M; Polat B
    Radiat Oncol; 2019 Dec; 14(1):227. PubMed ID: 31831026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distance to the neurooncological center: a negative prognostic factor in patients with glioblastoma multiforme. An epidemiological study.
    Kerschbaumer J; Freyschlag CF; Bauer R; Obwegeser AA; Schubert GA; Thomé C; Seiz M
    Anticancer Res; 2012 Dec; 32(12):5515-9. PubMed ID: 23225460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iridium-Knife: Another knife in radiation oncology.
    Milickovic N; Tselis N; Karagiannis E; Ferentinos K; Zamboglou N
    Brachytherapy; 2017; 16(4):884-892. PubMed ID: 28392144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.